TWIST1 and colorectal carcinoma: Conversely, silencing TWIST1 reversed the EMT phenotype, boosted the sensitivity of CRC cells to anticancer drugs both in vitro and in vivo, and decreased the expression of ABCB1 and ABCC1 [54].